Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

40.19
Delayed Data
As of 4:00pm ET
 -0.27 / -0.67%
Today’s Change
13.09
Today|||52-Week Range
52.35
+169.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization--0.008.0K9.0K
 
 
 
 
Operating ExpensesGross Income0.000.00-8.0K-9.0K
 
 
 
General Expenses7.7M6.1M8.4M8.6M
 
 
 
 
 
Research And Development5.5M4.4M6.8M6.7M
 
 
 
 
 
Total Operating Expenses7.7M6.1M8.4M8.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.7M-6.1M-8.4M-8.6M
 
 
 
 
 
Extraordinary Charge-73.0K0.000.000.00
 
 
Other Expenses0.000.000.00100.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M-6.0M-8.3M-8.4M
 
 
 
 
 
Net Income-7.7M-6.0M-8.3M-8.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M12.0M12.0M12.4M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M12.0M12.0M12.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.83-$0.50-$0.69-$0.68
 
 
 
 
 
EPS Diluted-$0.65-$0.50-$0.69-$0.68